Document is current

Any future updates will be listed below

Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis

Crossref DOI link: https://doi.org/10.1038/bmt.2014.318

Published Online: 2015-01-26

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark